GlassScriptPhysician profile
Mark Schwade
NPI 1720655285
$1,836.93
in general payments reported to CMS, 2019-2025
23 companies · $1,229 in 2025
The $1,229 reported for 2025 was more than what 88% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $29.55 · 2022: $144 · 2023: $65.51 · 2024: $369 · 2025: $1,229.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,663.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,663.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $321.17 | 2025 | Azure Xt Dr Mri Surescan, Cobalt Dr Mri Surescan, Linq II |
| Janssen Pharmaceuticals, INC | $275.13 | 2021-2024 | Xarelto |
| Kerecis Limited | $228.83 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Pfizer INC. | $158.27 | 2024-2025 | |
| Abbvie INC. | $122.24 | 2024-2025 | |
| Penumbra, INC. | $100.59 | 2025 | Indigo System |
| Novartis Pharmaceuticals Corporation | $73.70 | 2025 | |
| Lilly USA, LLC | $70.95 | 2024-2025 | Mounjaro, Zepbound |
| Shockwave Medical, INC | $54.50 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $54.46 | 2024-2025 | Lifevest |
| Abiomed | $49.13 | 2025 | |
| Stryker Corporation | $41.43 | 2025 | Flowtriever |
| Boehringer Ingelheim Pharmaceuticals, INC. | $40.42 | 2023 | Ofev |
| Scpharmaceuticals INC. | $34.45 | 2024 | |
| Edwards Lifesciences Corporation | $30.49 | 2025 | Sapien 3 Ultra Resilia |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $26.21 | 2025 | Winrevair |
| Averitas Pharma INC. | $25.58 | 2025 | Qutenza |
| Lundbeck LLC | $25.09 | 2023 | Vyepti |
| Fresenius USA Marketing, INC. | $23.08 | 2022 | |
| Theratechnologies INC. | $22.26 | 2022 | |
| Glaxosmithkline, LLC. | $21.71 | 2025 | Nucala |
| Inari Medical, INC. | $19.44 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Aurinia Pharma U.S., INC. | $17.80 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Schwade listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.